Abstract
Continuous peritoneal dialysis (CPD) is the preferred modality for renal replacement therapy in children with end-stage renal disease. Anterior ischemic optic neuropathy (AION) is a rare complication in patients on CPD. AION is characterized by ischemic injury of the optic nerve caused by hypoperfusion of the posterior ciliary arteries. It presents with acute visual loss and disc swelling, without additional neurological findings. We report a 2-year-old child with end-stage renal disease on CPD who developed AION. He was dehydrated and received intravenous fluid on admission. Additional treatment included methylprednisolone and levodopa. On his 3rd admission day, his pupils became reactive to light and his vision showed improvement. The improvement in vision might be due to the early detection and aggressive treatment of hypotension. It is difficult to demonstrate whether steroids or levodopa played a role in the improvement of his vision. Prospective studies to evaluate the effectiveness of levodopa in the treatment of AION are warranted in this potentially devastating condition.
This is a preview of subscription content, log in via an institution to check access.
References
Lapeyraque AL, Haddad E, Andre JL, Bremond-Gignac D, Taylor CM, Rianthavorn P, Salusky IB, Loirat C (2003) Sudden blindness caused by anterior ischemic optic neuropathy in 5 children on continuous peritoneal dialysis. Am J Kidney Dis 42:E3–E9
Chutorian AM, Winterkorn JMS, Geffner M (2002) Anterior ischemic optic neuropathy in children: case reports and review of the literature. Pediatr Neurol 26:358–364
Hayreh SS (1997) Anterior ischemic optic neuropathy. Clin Neurosci 47:251–263
Sevilla KS, Groggel GC (1986) Anterior ischemic optic neuropathy as a complication of hemodialysis. Am J Kidney Dis 8:61–63
Jackson TL, Farmer CKT, Kingswood C, Vickers S (1999) Hypotensive ischemic optic neuropathy and peritoneal dialysis. Am J Ophthalmol 128:109–111
Bates CM, Baum M, Hunchik M, Quan A (1999) Acute vision loss in children with autosomal recessive polycystic kidney disease. Am J Kidney Dis 34:1125–1128
Knox DL, Hanneken AM, Hollows FC, Miller NR, Schick HL, Gonzales WL (1988) Uremic optic neuropathy. Arch Ophthalmol 106:50–54
Ravelli M, Scaroni P, Mombelloni S, Movilli E, Feller P, Apostoli P, De Maria G, Valotti C, Sciuto G, Maiorca R (1990) Acute visual disorders in patients on regular dialysis given deferoxamine as a test. Nephrol Dial Transplant 5:945–949
Dukar O, Barr CC (1993) Visual loss complicating OKT3 monoclonal antibody therapy. Am J Ophthalmol 115:781–785
Chang D, Nagamoto G, Smith WE (1992) Benign intracranial hypertension and chronic renal failure. Cleve Clin J Med 59:419–422
Daugirdas JT (2001) Pathophysiology of dialysis hypotension, an update. Am J Kidney Dis 38 [Suppl 4]:S11–S17
Nicoara S, Macarie S, Vulpe V, Pop R (1995) Anterior ischemic optic neuropathy, The experience of 71 cases. Oftalmologia 39:125–129
Johnson LN, Gould TJ, Krohel GB (1996) Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior optic ischemic optic neuropathy of longer than six months duration. Am J Ophthalmol 121:77–83
Johnson LN, Guy M, Krohel G, Madsen R (2000) Levodopa may improve vision loss in recent onset, nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 107:521–526
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, J.S., Deputy, S., Vives, M.T. et al. Sudden blindness in a child with end-stage renal disease. Pediatr Nephrol 19, 691–693 (2004). https://doi.org/10.1007/s00467-004-1447-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-004-1447-7